CPIC specifications

Unique identifier:
Restrictions to use:
Data access:
File download, Browse
Clinical Pharmacogenetics Implementation Consortium
Community driven:
User data submission:
Not allowed


tutorial arrow
Communicate with other users
Participate in the forum to get support for using tools. Ask questions about technical specifications.
Take part in the discussion
Sign up for free to ask question and share your advices

No open topic.


tutorial arrow
Promote your skills
Define all the tasks you managed and assign your profile the appropriate badges. Become an active member.
Promote your work
Sign up for free to badge your contributorship



Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN, USA; Department of Genetics, Stanford University, Palo Alto, CA, USA; Centre for Addiction and Mental Health, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; Department of Clinical Pharmacology, Institute of Experimental and Clinical Pharmacology and Toxicology, University Hospital, Tuebingen, Germany; Department of Pharmacology, University of Extremadura, Cáceres, Spain; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA; Laboratory for Informatics Development, NIH Clinical Center, Bethesda, MD, USA; Laboratory for International Alliance on Genomic Research, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan; National Center for Genome Medicine, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan; School of Chinese Medicine, China Medical University, Taichung, Taiwan; Department of Medicine, Vanderbilt University, Nashville, TN, USA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Medical Sciences, Clinical Pharmacology, Uppsala University, Uppsala, Sweden; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands; Department of Pharmacology, Vanderbilt University, Nashville, TN, USA; Genomic Medicine Institute, Geisinger Health System, Danville, PN, USA; Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Denver, CO, USA; Clinical Pharmacy Services, Kaiser Permanente Colorado, Denver, CO, USA

Funding source(s)

This work was funded by the National Institutes of Health/National Institute of General Medical Science (NIH/NIGMS) (PAAR4Kids (UO1 GM92666), PharmGKB (R24 GM61374)), the Brain & Behavior Research Foundation Award, CIHR Michael Smith New Investigator Salary Prize for Research in Schizophrenia, the Ontario Mental Health Foundation New Investigator Fellowship, an Early Researcher Award by the Ministry of Research and Innovation of Ontario, the Swedish Research Council (Medicine 523-2008-5568 and 521-2011-2440), the Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Madrid, Spain (PI12/00241 and RETICS RD12/0013/0002), the NIH (T32 GM007569/GM/NIGMS), the NIH NIGMS (K23GM104401), the NIH/NIGMS U19 GM61388 and U19 HL065962.

User review

tutorial arrow
Vote up tools and offer feedback
Give value to tools and make your expertise visible
Give your feedback on this tool
Sign up for free to join and share with the community

0 user reviews

star_border star_border star_border star_border star_border
star star star star star

0 user reviews

star_border star_border star_border star_border star_border
star star star star star

No review has been posted.

Related Tools